LONDON/GENEVA (Reuters) – People infected in the West African Ebola outbreak can be offered untested drugs, the World Health Organization said on Tuesday, but the scarcity of supplies has raised questions about who gets priority access to treatment.
Liberia said it planned to treat two infected doctors with an unproven Ebola medicine called ZMapp. They would become the first Africans to receive the drug, which has been given to a Spanish priest who later died and two U.S. aid workers.
LONDON/GENEVA (Reuters) – People infected in the West Africa Ebola outbreak can be offered untested drugs, the World Health Organization said on Tuesday, but scarce supplies raise questions about who gets priority in the epidemic of the virus, which has no proven treatment.
Liberia said it planned to treat two infected doctors with an unproven Ebola medicine called ZMapp, the first Africans to receive the drug, while a Spanish priest, who the Health Ministry in Madrid said had also been given ZMapp, died.
LONDON/GENEVA (Reuters) – It is ethical to offer unproven drugs or vaccines to people infected or at risk in West Africa’s deadly Ebola outbreak, a World Health Organization panel of medical ethics experts ruled on Tuesday, but cautioned supplies will be limited.
The panel said any provision of experimental Ebola medicines would require “informed consent, freedom of choice, confidentiality, respect for the person, preservation of dignity and involvement of the community”.
LONDON, Aug 11 (Reuters) – After a month on the front line battling Ebola in a hospital in Sierra Leone, the memories that both haunt and inspire British doctor Tim O’Dempsey are of the children.
Many memories of children dying in isolation wards while their parents wailed outside. And one of a small girl who fought her way out of a coma and was reunited with her father.
LONDON/MONROVIA (Reuters) – West Africa’s Ebola epidemic constitutes an international health emergency and the virus, which has killed nearly 1,000 people, could continue spreading for months, the World Health Organization (WHO) said on Friday.
“The outbreak is moving faster than we can control it,” the WHO’s director-general Margaret Chan told reporters on a telephone briefing from the WHO’s Geneva headquarters.
LONDON (Reuters) – West Africa’s Ebola epidemic is an “extraordinary event” and now constitutes an international health risk, the World Health Organisation (WHO) said on Friday.
The Geneva-based U.N. health agency said the possible consequences of a further international spread of the outbreak, which has killed almost 1,000 people in four West African countries, were “particularly serious” in view of the virulence of the virus.
By Kate Kelland
LONDON (Reuters – Scientists who believed they had started to decipher links between a GlaxoSmithKline H1N1 pandemic flu vaccine and the sleep disorder narcolepsy have retracted a study after saying they cannot replicate their findings.
The paper, originally published in the journal Science Translational Medicine in December 2013, suggested narcolepsy can sometimes be triggered by a scientific phenomenon known as “molecular mimicry,” offering a possible explanation for its link to GSK’s “swine flu” vaccine, Pandemrix.
LONDON (Reuters) – Women with mutations in a gene called PALB2 have a one in three chance of developing breast cancer by age 70, according to research that suggests PALB2 is almost as important a risk factor as BRCA1 or BRCA2 mutations.
BRCA1 and BRCA2 are widely known as breast cancer risk genes. Women with a mutation in one or both often decide to have their breasts removed so they do not develop the disease.
GENEVA/LONDON (Reuters) – The use of an experimental drug on two U.S. charity workers with the deadly Ebola virus has prompted the World Health Organization (WHO) to consider the implications of making such treatments more widely available, it said on Wednesday.
The Geneva-based agency, which is hosting a two-day Emergency Committee of experts to decide on the international response to the disease that has killed nearly 1,000 people in West Africa, said it would convene a meeting of medical ethics experts early next week.
LONDON (Reuters) – Taking a small daily dose of aspirin can significantly reduce the risk of developing – or dying from – bowel, stomach and oesophageal cancer, according to a large review of scientific studies.
Researchers who analyzed all available evidence from studies and clinical trials assessing benefits and harm found that taking aspirin for 10 years could cut bowel cancer cases by around 35 percent and deaths from the disease by 40 percent.